<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03674385</url>
  </required_header>
  <id_info>
    <org_study_id>PHCL 191</org_study_id>
    <nct_id>NCT03674385</nct_id>
  </id_info>
  <brief_title>Efficacy of Vit E in PCOS Resistant to Clomiphene Citrate</brief_title>
  <official_title>Evaluation of the Clinical Outcome of Vitamin E as Adjuvant Therapy in Patients With Clomiphene Citrate Resistant Polycystic Ovary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Misr University for Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluate the addition of Vit E to clomiphene citrate in the treatment of poly
      cystic ovary.Half the patients will receive both Vit E and clomiphene citrate the other half
      will receive clomiphene citrate only.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clomiphene and vit E each used in treatment of pco but they do so by different mechanisms.

      Clomifene is in the selective estrogen receptor modulator (SERM) family of medication. It
      works by causing the release of gonadotropin-releasing hormone by the hypothalamus, and
      subsequently gonadotropin from the anterior pituitary.

      Vit E is used in treatment of pco due its anti-oxidant effect.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 19, 2018</start_date>
  <completion_date type="Actual">March 30, 2019</completion_date>
  <primary_completion_date type="Actual">March 25, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>prospective randomized controlled open label study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ovulation rate</measure>
    <time_frame>3 months</time_frame>
    <description>Follicles measure more than 18 mm will be considered mature follicles.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Clomiphene Citrate Resistant Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>vitamin E group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>clomiphene</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin E</intervention_name>
    <description>Vitamin E is sold as a dietary supplement, either by itself or incorporated into a multivitamin product. it also has anti-oxidant effect</description>
    <arm_group_label>vitamin E group</arm_group_label>
    <other_name>toco 1000</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin</intervention_name>
    <description>Metformin is in the biguanide class. It works by decreasing glucose production by the liver and increasing the insulin sensitivity of body tissues. It is also used in the treatment of polycystic ovary syndrome (PCOS)</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>vitamin E group</arm_group_label>
    <other_name>cidophage</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomiphene Citrate</intervention_name>
    <description>is a medication used to treat infertility in women who do not ovulate</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>vitamin E group</arm_group_label>
    <other_name>clomid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients will be diagnosed as having PCOS according to the Rotterdam criteria for
             diagnosis of PCOS

          2. Age between 18 and 39 years.

          3. Period of infertility &gt;1 years.

          4. No treatment taken during the last 2 months.

          5. Patients who have previously received clomiphene citrate (CC) and being diagnosed as
             having CC resistance

        Exclusion Criteria:

          1. History of pelvic surgery or infertility factor other than anovulation

          2. Endocrine disorders in the form of hypothyroidism or hyperthyroidism,
             hyperprolactinemia, and Cushing syndrome, as detected by history, examination, or
             investigations.

          3. Known cases of endometriosis (approved histologically), uterine anomaly or
             hydrosalpinx, retinitis pigmentosa and vitamin K deficiency.

          4. Consumption of vitamin and antioxidant supplementations in the last three-months
             before the trial start date.

          5. Male factor infertility (sperm count &lt; 5 million per milliliter, normal morphology
             &lt;4%).

          6. Elevated serum prolactin, T.S.H and F.S.H.

          7. Patients diagnosed with diabetes mellitus
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical Center of Infertility</name>
      <address>
        <city>BanÄ« Suwayf</city>
        <zip>62521</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 15, 2018</study_first_submitted>
  <study_first_submitted_qc>September 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2018</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Ahmed Abbas Morsy Morsy</investigator_full_name>
    <investigator_title>pharmacist</investigator_title>
  </responsible_party>
  <keyword>Vitamin E</keyword>
  <keyword>Polycystic ovary</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Metformin</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

